SE9300971D0 - HUDVAARDSKOMPOSITION - Google Patents

HUDVAARDSKOMPOSITION

Info

Publication number
SE9300971D0
SE9300971D0 SE19939300971A SE9300971A SE9300971D0 SE 9300971 D0 SE9300971 D0 SE 9300971D0 SE 19939300971 A SE19939300971 A SE 19939300971A SE 9300971 A SE9300971 A SE 9300971A SE 9300971 D0 SE9300971 D0 SE 9300971D0
Authority
SE
Sweden
Prior art keywords
cyclodextrin
conjugate
vitamin
beta
derivative
Prior art date
Application number
SE19939300971A
Other languages
Swedish (sv)
Inventor
*Wadstein Jan
*Samuelsson Mats
Original Assignee
Jan Wadstein
Mats Samuelsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Wadstein, Mats Samuelsson filed Critical Jan Wadstein
Priority to SE19939300971A priority Critical patent/SE9300971D0/en
Publication of SE9300971D0 publication Critical patent/SE9300971D0/en
Priority to AU63884/94A priority patent/AU6388494A/en
Priority to PCT/SE1994/000235 priority patent/WO1994021225A1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A skin care composition is disclosed, comprising as an active ingredient a conjugate of a vitamin A derivative and beta -cyclodextrin, and pharmaceutically acceptable carriers and/or fillers. There is also disclosed the use of a conjugate of a vitamin A derivative and beta -cyclodextrin and, optionally, colostrum for preparing a composition for therapeutic or prophylactic treatment of ageing symptoms in skin.
SE19939300971A 1993-03-24 1993-03-24 HUDVAARDSKOMPOSITION SE9300971D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE19939300971A SE9300971D0 (en) 1993-03-24 1993-03-24 HUDVAARDSKOMPOSITION
AU63884/94A AU6388494A (en) 1993-03-24 1994-03-17 Skin care composition
PCT/SE1994/000235 WO1994021225A1 (en) 1993-03-24 1994-03-17 Skin care composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939300971A SE9300971D0 (en) 1993-03-24 1993-03-24 HUDVAARDSKOMPOSITION

Publications (1)

Publication Number Publication Date
SE9300971D0 true SE9300971D0 (en) 1993-03-24

Family

ID=20389341

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939300971A SE9300971D0 (en) 1993-03-24 1993-03-24 HUDVAARDSKOMPOSITION

Country Status (3)

Country Link
AU (1) AU6388494A (en)
SE (1) SE9300971D0 (en)
WO (1) WO1994021225A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5653971A (en) * 1995-06-30 1997-08-05 The Gillette Company Shaving aid composite with an inclusion complex of a skin-soothing agent and a cyclodextrin
DE19619990A1 (en) * 1996-05-17 1997-11-20 Charlotte Adler Process for the production of colostral milk products and their use
JP3940209B2 (en) * 1996-11-14 2007-07-04 株式会社資生堂 Solubilized cosmetics
SE520645C2 (en) * 1996-11-15 2003-08-05 Interhealth Ab Therapeutic and cosmetic compositions, their use and method of preparation thereof
DE19713092A1 (en) * 1997-03-27 1998-10-01 Wacker Chemie Gmbh Complexes of gamma-cyclodextrin and retinol or retinol derivatives, as well as processes for their preparation and their use
SE9801647D0 (en) 1998-05-12 1998-05-12 Interhealth Ab Therapeutic composition
KR100404868B1 (en) * 2000-03-28 2003-11-15 김삼 Stable retinol palmitate and cosmetic composition containing the same
NO310176B1 (en) * 2000-11-13 2001-06-05 Wadlund As Composition for skin containing chitosan-conjugated CLA and chitosan-conjugated vitamin A or a <beta> -cyclodextrin-conjugated vitamin A and method of preparation and use thereof
DE10257246A1 (en) * 2002-12-07 2004-06-24 Beiersdorf Ag Aqueous or aqueous-alcoholic cosmetic or dermatological composition useful for matting shiny facial skin includes one or more powder raw materials selected from sugar derivatives
JP2006514991A (en) * 2002-12-27 2006-05-18 シエーリング アクチエンゲゼルシャフト New pharmaceutical combination
NO326950B1 (en) * 2006-09-20 2009-03-16 Pharma Medico Res Ltd Combination of a glucocorticoid and a β-cyclodextrin conjugated vitamin A derivative complex
NO20074043L (en) * 2007-08-06 2009-02-09 Spero As Skin care agent
US8410079B2 (en) * 2010-08-06 2013-04-02 Island Kinetics Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion
AU2013327489B2 (en) * 2012-10-02 2018-01-04 Allergan, Inc. Dermal filler hydrogels with vitamin A/cyclodextrin inclusion complexes
US20140234433A1 (en) * 2013-02-15 2014-08-21 Nicholas V. Perricone Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
FR2628973B1 (en) * 1988-03-25 1990-11-16 Gattefosse Ets Sa COSMETIC OR PHARMACEUTICAL COMPOSITION FOR SKIN USE, AND PROCESS FOR THE PREPARATION OF SUCH A COMPOSITION
AU616571B2 (en) * 1988-10-28 1991-10-31 Shiseido Company Ltd. Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
FR2647015B1 (en) * 1989-05-17 1994-05-06 Cird AQUEOUS GEL BASED ON RETINOIC ACID AND ITS USE IN HUMAN MEDICINE AND COSMETICS
LU87843A1 (en) * 1990-11-15 1992-08-25 Cird Galderma AQUEOUS GEL BASED ON RETINOIC ACID AND HYDROXYPROPYL-BETA-CYCLODEXTRIN AND ITS USE IN HUMAN MEDICINE AND COSMETICS

Also Published As

Publication number Publication date
WO1994021225A1 (en) 1994-09-29
AU6388494A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
SE9300971D0 (en) HUDVAARDSKOMPOSITION
UA56989C2 (en) PHYSIOLOGICALLY ACTIVE PEG-CONJUGATE OF a-INTERFERON, A METHOD FOR PREPARING THE SAME, A PHARMACEUTICAL COMPOSITION BASED THEREON AND A METHOD FOR TREATMENT OR PROPHYLAXIS OF IMMUNOMODULAR DISEASES
CY1109869T1 (en) MANUFACTURE OF SHOPS AND PHARMACEUTICAL PARTS OF THEIR SALTS
FI956014A0 (en) Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
BR9712523A (en) New heterocyclyl-substituted pyrazole derivatives
EP0504938A3 (en) Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
CA2204277A1 (en) Combined meningitis vaccine
AU2905092A (en) Pharmaceutical dipeptide compositions and methods of use thereof
AR016798A1 (en) USE OF A LACTOBACILLUS CEPA FOR THE PREPARATION OF A MEDICINAL PRODUCT
GR3019625T3 (en) Topically administered compositions based on high molecular weight hyaluronic acid for treating inflammations of the oral cavity, and for oral cavity hygiene and cosmetic treatment
PT998287E (en) USES OF LEVOBUPIVACAINE
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
NO20000446D0 (en) Use of physiologically acceptable vanadium compounds, salts and complexes
GB9103764D0 (en) Compositions
AU6924698A (en) Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
TR200102512T2 (en) The use of saredutan and its pharmaceutically acceptable salts for the preparation of medicinal products useful in the treatment or prevention of all mental disorders, adaptation disorders and various anxiety-depression disorders.
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
MX9707642A (en) Pharmaceutical agents for the treatment of alzheimer&#39;s disease.
AU3401093A (en) Therapeutic agent for threatened abortion
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
AU2337900A (en) Preparation for warts
ATE293445T1 (en) PRODUCTION OF PURE STEREOISOMERS OF TRICYCLO-(5.2.1.0(2.6))-DEC-9-YL-XANTHOGENATE AND THEIR USE AS MEDICINAL PRODUCTS